Clinical trial
NATIVE Sequence for Non-Contrast MR Angiogram Compared With Conventional Contrast Enhanced 3D MRA on 3T Verio Magnet
NCT02065648 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NATIVE Sequence for Non-Contrast MR Angiogram Compared With Conventional Contrast Enhanced 3D MRA on 3T Verio Magnet
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- March 31, 2015
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vascular disease